Kalp ve Damar Hastalıklarının Tanısında Manyetik Rezonans Görüntüleme

Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: part I. Journal of Cardiovascular Magnetic Resonance. 2010;12(1):71.

Axel L, Toms MA. Clinical cardiac magnetic resonance imaging techniques. Cardiovascular Magnetic Resonance Imaging. 2019:17-50.

Currie S, Hoggard N, Craven IJ, Hadjivassiliou M, Wilkinson ID. Understanding MRI: basic MR physics for physicians. Postgraduate medical journal. 2013;89(1050):209-23.

Brown RW, Cheng Y-CN, Haacke EM, Thompson MR, Venkatesan R. Magnetic resonance imaging: physical principles and sequence design: John Wiley & Sons; 2014.

Anderson L, Holden S, Davis B, Prescott E, Charrier C, Bunce N, et al. Cardiovascular T2- star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. European heart journal. 2001;22(23):2171-9.

von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: a comprehensive summary and update. Journal of Cardiovascular Magnetic Resonance. 2023;25(1):42.

Markl M. Techniques in the assessment of cardiovascular blood flow and velocity. Cardiovascular Magnetic Resonance Imaging. 2019:113-25.

Members WC, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin III JP, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2021;77(4):e25-e197.

Gatehouse PD, Keegan J, Crowe LA, Masood S, Mohiaddin RH, Kreitner K-F, et al. Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. European radiology. 2005;15:2172-84.

Wigström L, Ebbers T, Fyrenius A, Karlsson M, Engvall J, Wranne B, et al. Particle trace visualization of intracardiac flow using time‐resolved 3D phase contrast MRI. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine. 1999;41(4):793-9.

Sträter A, Huber A, Rudolph J, Berndt M, Rasper M, Rummeny EJ, et al., editors. 4D-flow MRI: technique and applications. RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren; 2018: © Georg Thieme Verlag KG.

Markl M, Geiger J, Arnold R, Stroh A, Damjanovic D, Föll D, et al. Comprehensive 4- dimensional magnetic resonance flow analysis after successful heart transplantation resolves controversial intraoperative findings and reveals complex hemodynamic alterations. Circulation. 2011;123(11):e381-e3.

Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. Journal of Cardiovascular Magnetic Resonance. 2020;22(1):19.

Patel AR, Salerno M, Kwong RY, Singh A, Heydari B, Kramer CM. Stress cardiac magnetic resonance myocardial perfusion imaging: JACC review topic of the week. Journal of the American College of Cardiology. 2021;78(16):1655-68.

Danad I, Szymonifka J, Twisk JW, Norgaard BL, Zarins CK, Knaapen P, et al. Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis. European heart journal. 2017;38(13):991-8.

Knott KD, Seraphim A, Augusto JB, Xue H, Chacko L, Aung N, et al. The prognostic significance of quantitative myocardial perfusion: an artificial intelligence–based approach using perfusion mapping. Circulation. 2020;141(16):1282-91.

Sammut EC, Villa AD, Di Giovine G, Dancy L, Bosio F, Gibbs T, et al. Prognostic value of quantitative stress perfusion cardiac magnetic resonance. JACC: Cardiovascular Imaging. 2018;11(5):686-94.

Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. Journal of Cardiovascular Magnetic Resonance. 2020;22(1):17.

Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. The American journal of cardiology. 1971;27(4):416-32.

Ruffolo Jr RR. The pharmacology of dobutamine. The American journal of the medical sciences. 1987;294(4):244-8.

Zareba KM, Raman SV. Exercise and Dobutamine Stress CMR. Cardiovascular Magnetic Resonance Imaging. 2019:175-84.

Lubbers DD, Janssen CH, Kuijpers D, Van Dijkman PR, Overbosch J, Willems TP, et al. The additional value of first pass myocardial perfusion imaging during peak dose of dobutamine stress cardiac MRI for the detection of myocardial ischemia. The international journal of cardiovascular imaging. 2008;24:69-76.

Nagel E, Lorenz C, Baer F, Hundley WG, Wilke N, Neubauer S, et al. Stress cardiovascular magnetic resonance: consensus panel report. Journal of Cardiovascular Magnetic Resonance. 2001;3(3):267-81.

Feng L, Donnino R, Babb J, Axel L, Kim D. Numerical and in vivo validation of fast cine displacement‐encoded with stimulated echoes (DENSE) MRI for quantification of regional cardiac function. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2009;62(3):682-90.

Xu C, Pilla JJ, Isaac G, Gorman III JH, Blom AS, Gorman RC, et al. Deformation analysis of 3D tagged cardiac images using an optical flow method. Journal of Cardiovascular Magnetic Resonance. 2010;12(1):19.

Neizel M, Lossnitzer D, Korosoglou G, Schäufele T, Lewien A, Steen H, et al. Strain‐ encoded (SENC) magnetic resonance imaging to evaluate regional heterogeneity of myocardial strain in healthy volunteers: Comparison with conventional tagging. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2009;29(1):99-105.

Schuster A, Kutty S, Padiyath A, Parish V, Gribben P, Danford DA, et al. Cardiovascular magnetic resonance myocardial feature tracking detects quantitative wall motion during dobutamine stress. Journal of Cardiovascular Magnetic Resonance. 2011;13(1):58.

Han Y, Witschey WR, Duffy K, Ferrari VA. Regional myocardial strain and function: from novel techniques to clinical applications. Cardiovascular Magnetic Resonance Imaging. 2019:87- 98.

Parsai C, O’Hanlon R, Prasad SK, Mohiaddin RH. Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. Journal of Cardiovascular Magnetic Resonance. 2012;14(1):1-24.

Forleo C, Carella MC, Basile P, Mandunzio D, Greco G, Napoli G, et al. The Role of Magnetic Resonance Imaging in Cardiomyopathies in the Light of New Guidelines: A Focus on Tissue Mapping. Journal of Clinical Medicine. 2024;13(9):2621.

Ogier AC, Bustin A, Cochet H, Schwitter J, van Heeswijk RB. The Road Toward Reproducibility of Parametric Mapping of the Heart: A Technical Review. Frontiers in Cardiovascular Medicine. 2022;9.

Graaf W, Vandoorne K, Arslan F, Nicolay K, Strijkers G. Contrast-Enhanced T1-Mapping MRI for the Assessment of Myocardial Fibrosis. Current Cardiovascular Imaging Reports. 2014;7.

Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). Journal of Cardiovascular Magnetic Resonance. 2017;19(1):1-24.

Radenkovic D, Weingärtner S, Ricketts L, Moon JC, Captur G. T1 mapping in cardiac MRI. Heart Failure Reviews. 2017;22(4):415-30.

Kramer CM, Chandrashekhar Y, Narula J. T1 mapping by CMR in cardiomyopathy: a noninvasive myocardial biopsy? : American College of Cardiology Foundation Washington, DC; 2013. p. 532-4.

Pica S, Sado DM, Maestrini V, Fontana M, White SK, Treibel T, et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 2014;16(1):99.

Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA, et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. European Heart Journal-Cardiovascular Imaging. 2015;16(1):14-22.

Todiere G, Barison A, Baritussio A, Cipriani A, Guaricci AI, Pica S, et al. Acute clinical presentation of nonischemic cardiomyopathies: Early detection by cardiovascular magnetic resonance. Journal of Cardiovascular Medicine. 2023;24(Supplement 1):e36-e46.

Özcan Ç, Yiğit H, Çetin MS, Özcan İ. Analysis of myocardial T1, T2, and T2* values by age, sex, and cardiac segments in normal population: a prospective study. The International Journal of Cardiovascular Imaging. 2024.

Nishii T, Kono AK, Shigeru M, Takamine S, Fujiwara S, Kyotani K, et al. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy. The international journal of cardiovascular imaging. 2014;30(1):65-72.

Lurz P, Luecke C, Eitel I, Föhrenbach F, Frank C, Grothoff M, et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-Trial. Journal of the American College of Cardiology. 2016;67(15):1800-11.

Friedrich MG, Marcotte F. Cardiac magnetic resonance assessment of myocarditis. Circulation: Cardiovascular Imaging. 2013;6(5):833-9.

Masci P-G, Pavon AG, Muller O, Iglesias J-F, Vincenti G, Monney P, et al. Relationship between CMR-derived parameters of ischemia/reperfusion injury and the timing of CMR after reperfused ST-segment elevation myocardial infarction. Journal of cardiovascular magnetic resonance. 2018;20(1):50.

Dorniak K, Stopczyńska I, van Heeswijk RB, Żaczyńska-Buchowiecka M, Fijałkowska J, Glińska A, et al. Cardiac magnetic resonance imaging with T2 mapping for the monitoring of acute heart transplant rejection in patients with problematic endomyocardial biopsy: in anticipation of new recommendations. Kardiologia Polska (Polish Heart Journal). 2021;79(3):339-43.

Koohi F, Kazemi T, Miri-Moghaddam E. Cardiac complications and iron overload in beta thalassemia major patients—a systematic review and meta-analysis. Annals of hematology. 2019;98(6):1323-31.

Pennell DJ, Porter JB, Piga A, Lai YR, El‐Beshlawy A, Elalfy M, et al. Sustained improvements in myocardial T2* over 2 years in severely iron‐overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine. American Journal of Hematology. 2015;90(2):91-6.

Chen Y, Ren D, Guan X, Yang H-J, Liu T, Tang R, et al. Quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5 T with ex-vivo validation. Journal of Cardiovascular Magnetic Resonance. 2021;23(1):104.

Thompson EW, Kamesh Iyer S, Solomon MP, Li Z, Zhang Q, Piechnik S, et al. Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Journal of Cardiovascular Magnetic Resonance. 2021;23:1-9.

van Oorschot JW, Güçlü F, de Jong S, Chamuleau SA, Luijten PR, Leiner T, et al. Endogenous assessment of diffuse myocardial fibrosis in patients with T1ρ‐mapping. Journal of Magnetic Resonance Imaging. 2017;45(1):132-8.

Triadyaksa P, Oudkerk M, Sijens PE. Cardiac T2* mapping: Techniques and clinical applications. Journal of Magnetic Resonance Imaging. 2020;52(5):1340-51.

Safety: EPoM, Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley Jr WG, et al. ACR guidance document on MR safe practices: 2013. Journal of Magnetic Resonance Imaging. 2013;37(3):501-30.

Tsai LL, Grant AK, Mortele KJ, Kung JW, Smith MP. A practical guide to MR imaging safety: what radiologists need to know. Radiographics. 2015;35(6):1722-37.

Özdemir H, Ağıldere AM. Manyetik Rezonans Görüntülemede Donanım ve Güvenlik. Türk Radyoloji Seminerleri, Türk Radyoloji Derneği. 2020.

Sammet S. Magnetic resonance safety. Abdominal radiology. 2016;41:444-51.

Derneği TR. MR Güvenlik Kılavuzu: Türk Radyoloji Derneği; 2019 [Available from: https://www.turkrad.org.tr/assets/DernektenHaberler-Pdf/MR-Guvenlik-Kilavuzu-09-12-2019.pdf.

Byrne RA, Rossello X, Coughlan J, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal: Acute Cardiovascular Care. 2024;13(1):55-161.

Harrington RA, Fuster V, Narula J, Eapen ZJ. Hurst's the Heart, 14th Edition: Two Volume Set: McGraw-Hill Education; 2017.

Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Comparison of low- dose dobutamine–gradient-echo magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in patients with chronic coronary artery disease: a functional and morphological approach to the detection of residual myocardial viability. Circulation. 1995;91(4):1006-15.

Wellnhofer E, Olariu A, Klein C, Gräfe M, Wahl A, Fleck E, et al. Magnetic resonance low- dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation. 2004;109(18):2172-4.

Takx RA, Blomberg BA, Aidi HE, Habets J, de Jong PA, Nagel E, et al. Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circulation: Cardiovascular Imaging. 2015;8(1):e002666.

de Jong MC, Genders TS, van Geuns R-J, Moelker A, Hunink MM. Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta- analysis. European radiology. 2012;22:1881-95.

Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. The Lancet. 2012;379(9814):453-60.

Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast- enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. The Lancet. 2003;361(9355):374-9.

Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104(10):1101-7.

O'Brien AT, Gil KE, Varghese J, Simonetti OP, Zareba KM. T2 mapping in myocardial disease: a comprehensive review. Journal of Cardiovascular Magnetic Resonance. 2022;24(1):33.

Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. Journal of the American College of Cardiology. 2009;54(4):281-92.

Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FA, et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. Journal of the American College of Cardiology. 2009;54(23):2145-53.

Hamirani YS, Wong A, Kramer CM, Salerno M. Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. JACC: Cardiovascular Imaging. 2014;7(9):940-52.

Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de Werf F, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. European heart journal. 2009;30(12):1440-9.

Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503-626.

Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. European heart journal. 2008;29(2):270-6.

Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. European heart journal. 2016;37(23):1850-8.

Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13):1533-41.

Rapezzi C, Aimo A, Barison A, Emdin M, Porcari A, Linhart A, et al. Restrictive cardiomyopathy: definition and diagnosis. European heart journal. 2022;43(45):4679-93.

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2021;42(36):3599-726.

Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109(10):1250-8.

Puntmann VO, Carr-White G, Jabbour A, Yu C-Y, Gebker R, Kelle S, et al. T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC: Cardiovascular Imaging. 2016;9(1):40-50.

Vita T, Gräni C, Abbasi SA, Neilan TG, Rowin E, Kaneko K, et al. Comparing CMR mapping methods and myocardial patterns toward heart failure outcomes in nonischemic dilated cardiomyopathy. JACC: Cardiovascular Imaging. 2019;12(8 Part 2):1659-69.

Cadour F, Quemeneur M, Biere L, Donal E, Bentatou Z, Eicher J-C, et al. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy. Journal of Cardiovascular Magnetic Resonance. 2023;25(1):7.

Mordi I, Carrick D, Bezerra H, Tzemos N. T 1 and T 2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. European Heart Journal-Cardiovascular Imaging. 2016;17(7):797-803.

Friedrich MG. Myocardial edema—a new clinical entity? Nature Reviews Cardiology. 2010;7(5):292-6.

Xu Y, Li W, Wan K, Liang Y, Jiang X, Wang J, et al. Myocardial tissue reverse remodeling after guideline-directed medical therapy in idiopathic dilated cardiomyopathy. Circulation: Heart Failure. 2021;14(1):e007944.

Gigli M, Stolfo D, Merlo M, Barbati G, Ramani F, Brun F, et al. Insights into mildly dilated cardiomyopathy: temporal evolution and long‐term prognosis. European Journal of Heart Failure. 2017;19(4):531-9.

Donal E, Delgado V, Bucciarelli-Ducci C, Galli E, Haugaa KH, Charron P, et al. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging. European Heart Journal-Cardiovascular Imaging. 2019;20(10):1075-93.

Eda Y, Nabeta T, Iikura S, Takigami Y, Fujita T, Iida Y, et al. Non‐dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes. ESC Heart Failure. 2024.

Kampmann C, Wiethoff C, Wenzel A, Stolz G, Betancor M, Wippermann C, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart. 2000;83(6):667-72.

Tore D, Faletti R, Gaetani C, Bozzo E, Biondo A, Carisio A, et al. Cardiac magnetic resonance of hypertrophic heart phenotype: A review. Heliyon. 2023;9(6).

Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008;118(15):1541-9.

Weinsaft JW, Kim HW, Crowley AL, Klem I, Shenoy C, Van Assche L, et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC: Cardiovascular Imaging. 2011;4(7):702-12.

Brouwer WP, Germans T, Head MC, van der Velden J, Heymans MW, Christiaans I, et al. Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers. European Heart Journal–Cardiovascular Imaging. 2012;13(4):292-7.

Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, et al. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circulation: Cardiovascular Imaging. 2012;5(4):441-7.

Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, et al. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. Journal of the American College of Cardiology. 2006;48(12):2518-23.

Rudolph A, Abdel-Aty H, Bohl S, Boyé P, Zagrosek A, Dietz R, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy: relation to remodeling. Journal of the American College of Cardiology. 2009;53(3):284-91.

Moon JC, Reed E, Sheppard MN, Elkington AG, Ho S, Burke M, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2004;43(12):2260-4.

Cardiology ACo, Cardiology ACo, Association AH. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142(25):E558-E631.

Kamp NJ, Chery G, Kosinski AS, Desai MY, Wazni O, Schmidler GS, et al. Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis. Progress in Cardiovascular Diseases. 2021;66:10-6.

Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circulation: Cardiovascular Imaging. 2012;5(6):726-33.

Xu J, Zhuang B, Sirajuddin A, Li S, Huang J, Yin G, et al. MRI T1 mapping in hypertrophic cardiomyopathy: evaluation in patients without late gadolinium enhancement and hemodynamic obstruction. Radiology. 2020;294(2):275-86.

Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, et al. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circulation: Cardiovascular Imaging. 2013;6(3):415- 22.

Huang L, Ran L, Zhao P, Tang D, Han R, Ai T, et al. MRI native T1 and T2 mapping of myocardial segments in hypertrophic cardiomyopathy: tissue remodeling manifested prior to structure changes. The British Journal of Radiology. 2019;92(1104):20190634.

Gastl M, Lachmann V, Christidi A, Janzarik N, Veulemans V, Haberkorn S, et al. Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM. European Radiology. 2021;31:2768-77.

Corrado D, Marra MP, Zorzi A, Beffagna G, Cipriani A, De Lazzari M, et al. Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria. International journal of cardiology. 2020;319:106-14.

Borgquist R, Haugaa KH, Gilljam T, Bundgaard H, Hansen J, Eschen O, et al. The diagnostic performance of imaging methods in ARVC using the 2010 Task Force criteria. European Heart Journal–Cardiovascular Imaging. 2014;15(11):1219-25.

Dalal D, Tandri H, Judge DP, Amat N, Macedo R, Jain R, et al. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy: a genetics–magnetic resonance imaging correlation study. Journal of the American College of Cardiology. 2009;53(15):1289-99.

Muscogiuri G, Fusini L, Ricci F, Sicuso R, Guglielmo M, Baggiano A, et al. Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy. International Journal of Cardiology. 2021;339:203-10.

Quarta G, Husain SI, Flett AS, Sado DM, Chao CY, Tomé Esteban MT, et al. Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 2013;15:1-7.

Heermann P, Fritsch H, Koopmann M, Sporns P, Paul M, Heindel W, et al. Biventricular myocardial strain analysis using cardiac magnetic resonance feature tracking (CMR-FT) in patients with distinct types of right ventricular diseases comparing arrhythmogenic right ventricular cardiomyopathy (ARVC), right ventricular outflow-tract tachycardia (RVOT-VT), and Brugada syndrome (BrS). Clinical Research in Cardiology. 2019;108:1147-62.

Zghaib T, Ghasabeh MA, Assis FR, Chrispin J, Keramati A, Misra S, et al. Regional strain by cardiac magnetic resonance imaging improves detection of right ventricular scar compared with late gadolinium enhancement on a multimodality scar evaluation in patients with arrhythmogenic right ventricular cardiomyopathy. Circulation: Cardiovascular Imaging. 2018;11(9):e007546.

Rastegar N, Burt JR, Corona-Villalobos CP, Te Riele AS, James CA, Murray B, et al. Cardiac MR findings and potential diagnostic pitfalls in patients evaluated for arrhythmogenic right ventricular cardiomyopathy. Radiographics. 2014;34(6):1553-70.

Aquaro GD, Barison A, Todiere G, Grigoratos C, Ali LA, Di Bella G, et al. Usefulness of combined functional assessment by cardiac magnetic resonance and tissue characterization versus task force criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy. The American journal of cardiology. 2016;118(11):1730-6.

Al’Aref SJ, Altibi AM, Malkawi A, Mansour M, Baskaran L, Masri A, et al. Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy. European Heart Journal-Cardiovascular Imaging. 2023;24(4):472-82.

Cipriani A, Mattesi G, Bariani R, Cecere A, Martini N, De Michieli L, et al. Cardiac magnetic resonance imaging of arrhythmogenic cardiomyopathy: evolving diagnostic perspectives. European Radiology. 2023;33(1):270-82.

Casella M, Gasperetti A, Sicuso R, Conte E, Catto V, Sommariva E, et al. Characteristics of patients with arrhythmogenic left ventricular cardiomyopathy: combining genetic and histopathologic findings. Circulation: Arrhythmia and Electrophysiology. 2020;13(12):e009005.

Bourfiss M, Prakken NH, van der Heijden JF, Kamel I, Zimmerman SL, Asselbergs FW, et al. Diagnostic value of native T1 mapping in arrhythmogenic right ventricular cardiomyopathy. JACC: Cardiovascular Imaging. 2019;12(8 Part 1):1580-2.

Habib G, Bucciarelli-Ducci C, Caforio AL, Cardim N, Charron P, Cosyns B, et al. Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography. European Heart Journal-Cardiovascular Imaging. 2017;18(10):1090-121.

Saeed M, Liu H, Liang C-H, Wilson MW. Magnetic resonance imaging for characterizing myocardial diseases. The international journal of cardiovascular imaging. 2017;33:1395-414.

Arbustini E, Morbini P, Grasso M, Fasani R, Verga L, Bellini O, et al. Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin- immunoreactive material deposits. Journal of the American College of Cardiology. 1998;31(3):645-53.

van Waning JI, Caliskan K, Michels M, Schinkel AF, Hirsch A, Dalinghaus M, et al. Cardiac phenotypes, genetics, and risks in familial noncompaction cardiomyopathy. Journal of the American College of Cardiology. 2019;73(13):1601-11.

Jensen B, van der Wal AC, Moorman AF, Christoffels VM. Excessive trabeculations in noncompaction do not have the embryonic identity. International journal of cardiology. 2017;227:325-30.

de la Chica JA, Gomez-Talavera S, Garcia-Ruiz JM, Garcia-Lunar I, Oliva B, Fernández- Alvira JM, et al. Association between left ventricular noncompaction and vigorous physical activity. Journal of the American College of Cardiology. 2020;76(15):1723-33.

Faber JW, D'Silva A, Christoffels VM, Jensen B. Lack of morphometric evidence for ventricular compaction in humans. Journal of cardiology. 2021;78(5):397-405.

Anderson RH, Jensen B, Mohun TJ, Petersen SE, Aung N, Zemrak F, et al. Key questions relating to left ventricular noncompaction cardiomyopathy: is the emperor still wearing any clothes? Canadian Journal of Cardiology. 2017;33(6):747-57.

Kohli SK, Pantazis AA, Shah JS, Adeyemi B, Jackson G, McKenna WJ, et al. Diagnosis of left- ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? European heart journal. 2008;29(1):89-95.

Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. Journal of the American College of Cardiology. 2005;46(1):101-5.

Jacquier A, Thuny F, Jop B, Giorgi R, Cohen F, Gaubert J-Y, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. European heart journal. 2010;31(9):1098-104.

Nucifora G, Aquaro GD, Pingitore A, Masci PG, Lombardi M. Myocardial fibrosis in isolated left ventricular non‐compaction and its relation to disease severity. European journal of heart failure. 2011;13(2):170-6.

Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis―Digest version―. Circulation Journal. 2019;83(11):2329-88.

Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart rhythm. 2014;11(7):1304-23.

A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. European Heart Journal-Cardiovascular Imaging. 2017;18(10):1073-89.

Zhang J, Li Y, Xu Q, Xu B, Wang H. Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: a meta‐analysis. Canadian Respiratory Journal. 2018;2018(1):7457369.

Tan JL, Fong HK, Birati EY, Han Y. Cardiac sarcoidosis. The American journal of cardiology. 2019;123(3):513-22.

Tan JL, Bryan E, Tan X, Cheung JW, Ortman M, Lee JZ. Update on cardiac sarcoidosis. Trends in Cardiovascular Medicine. 2023;33(7):442-55.

Velangi PS, Chen K-HA, Kazmirczak F, Okasha O, von Wald L, Roukoz H, et al. Right ventricular abnormalities on cardiovascular magnetic resonance imaging in patients with sarcoidosis. Cardiovascular Imaging. 2020;13(6):1395-405.

Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E. T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology. 2017;285(1):63-72.

Dabir D, Meyer D, Kuetting D, Luetkens J, Homsi R, Pizarro C, et al., editors. Diagnostic value of cardiac magnetic resonance strain analysis for detection of cardiac sarcoidosis. RöFo- Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren; 2018: © Georg Thieme Verlag KG.

Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S, et al. Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta- analysis. Circulation: Cardiovascular Imaging. 2016;9(9):e005001.

Dabir D, Luetkens J, Kuetting D, Nadal J, Schild HH, Thomas D, editors. Myocardial mapping in systemic sarcoidosis: a comparison of two measurement approaches. RöFo- Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren; 2021: Georg Thieme Verlag KG.

Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation. 2011;124(20):2253-63.

Wood JC. Magnetic resonance imaging measurement of iron overload. Current opinion in hematology. 2007;14(3):183-90.

Casale M, Filosa A, Ragozzino A, Amendola G, Roberti D, Tartaglione I, et al. Long‐term improvement in cardiac magnetic resonance in β‐thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function. American Journal of Hematology. 2019;94(3):312-8.

Pepe A, Meloni A, Rossi G, Midiri M, Missere M, Valeri G, et al. Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach. European Heart Journal- Cardiovascular Imaging. 2018;19(3):299-309.

Hanneman K, Nguyen ET, Thavendiranathan P, Ward R, Greiser A, Jolly M-P, et al. Quantification of myocardial extracellular volume fraction with cardiac MR imaging in thalassemia major. Radiology. 2016;279(3):720-30.

Tahir E, Fischer R, Grosse R, Tavrovski P, Yamamura J, Starekova J, et al. Strain analysis using feature-tracking CMR to detect LV systolic dysfunction in myocardial iron overload disease. Cardiovascular Imaging. 2020;13(10):2267-8.

Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. Jama. 2011;306(3):277-86.

Razvi Y, Patel RK, Fontana M, Gillmore JD. Cardiac amyloidosis: a review of current imaging techniques. Frontiers in Cardiovascular Medicine. 2021;8:751293.

Pagura L, Porcari A, Cameli M, Biagini E, Canepa M, Crotti L, et al. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study. European Journal of Internal Medicine. 2024;122:68-77.

Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, et al. Magnetic resonance in transthyretin cardiac amyloidosis. Journal of the American College of Cardiology. 2017;70(4):466-77.

Martinez-Naharro A, Kotecha T, Norrington K, Boldrini M, Rezk T, Quarta C, et al. Native T1 and extracellular volume in transthyretin amyloidosis. JACC: Cardiovascular Imaging. 2019;12(5):810-9.

Williams LK, Forero JF, Popovic ZB, Phelan D, Delgado D, Rakowski H, et al. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics. Journal of Cardiovascular Magnetic Resonance. 2016;19(1):61.

Ioannou A, Patel RK, Martinez-Naharro A, Razvi Y, Porcari A, Rauf MU, et al. Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping. JAMA cardiology. 2023;8(9):848-52.

Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. European heart journal. 2021;42(16):1554-68.

Gama F, Rosmini S, Bandula S, Patel KP, Massa P, Tobon-Gomez C, et al. Extracellular volume fraction by computed tomography predicts long-term prognosis among patients with cardiac amyloidosis. Cardiovascular Imaging. 2022;15(12):2082-94.

Ponsiglione A, De Giorgi M, Ascione R, Nappi C, Sanduzzi L, Pisani A, et al. Advanced CMR techniques in Anderson-Fabry disease: state of the art. Diagnostics. 2023;13(15):2598.

Militaru S, Ginghină C, Popescu BA, Săftoiu A, Linhart A, Jurcuţ R. Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets. European Heart Journal- Cardiovascular Imaging. 2018;19(12):1313-22.

Kozor R, Callaghan F, Tchan M, Hamilton-Craig C, Figtree GA, Grieve SM. A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease. Journal of Cardiovascular Magnetic Resonance. 2015;17(1):22.

Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC, et al. Cardiac involvement in Fabry disease: JACC review topic of the week. Journal of the American College of Cardiology. 2021;77(7):922-36.

Frustaci A, Verardo R, Grande C, Galea N, Piselli P, Carbone I, et al. Immune‐Mediated myocarditis in Fabry disease cardiomyopathy. Journal of the American Heart Association. 2018;7(17):e009052.

Perry R, Shah R, Saiedi M, Patil S, Ganesan A, Linhart A, et al. The role of cardiac imaging in the diagnosis and management of Anderson-Fabry disease. JACC: Cardiovascular Imaging. 2019;12(7 Part 1):1230-42.

Augusto JB, Nordin S, Vijapurapu R, Baig S, Bulluck H, Castelletti S, et al. Myocardial edema, myocyte injury, and disease severity in Fabry disease. Circulation: Cardiovascular Imaging. 2020;13(3):e010171.

Heidecker B, Dagan N, Balicer R, Eriksson U, Rosano G, Coats A, et al. Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. European journal of heart failure. 2022;24(11):2000-18.

Members WC, Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2021;78(22):e187- e285.

Ferreira VM, Plein S, Wong TC, Tao Q, Raisi-Estabragh Z, Jain SS, et al. Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance. Journal of Cardiovascular Magnetic Resonance. 2023;25(1):21.

Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. Journal of the American College of Cardiology. 2018;72(24):3158-76.

Francone M, Aquaro GD, Barison A, Castelletti S, de Cobelli F, de Lazzari M, et al. Appropriate use criteria for cardiovascular MRI: SIC–SIRM position paper Part 2 (myocarditis, pericardial disease, cardiomyopathies and valvular heart disease). Journal of Cardiovascular Medicine. 2021;22(7):515-29.

Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. Journal of the American College of Cardiology. 2009;53(17):1475-87.

Leiner T, Bogaert J, Friedrich MG, Mohiaddin R, Muthurangu V, Myerson S, et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 2020;22(1):76.

Committee W, Drazner MH, Bozkurt B, Cooper LT, Aggarwal NR, Basso C, et al. 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2024.

Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. Journal of Cardiovascular Magnetic Resonance. 2016;18(1):89.

Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, et al. Long-term follow- up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. Journal of the American College of Cardiology. 2012;59(18):1604-15.

Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes. Journal of the American College of Cardiology. 2017;70(19):2363-75.

Chen Y, Sun Z, Xu L, Liu J, Li Y, Zhang N, et al. Diagnostic and prognostic value of cardiac magnetic resonance strain in suspected myocarditis with preserved LV‐EF: A comparison between patients with negative and positive late gadolinium enhancement findings. Journal of Magnetic Resonance Imaging. 2022;55(4):1109-19.

Isaak A, Kravchenko D, Mesropyan N, Endler C, Bischoff LM, Vollbrecht T, et al. Layer- specific strain analysis with cardiac MRI feature tracking in acute myocarditis. Radiology: Cardiothoracic Imaging. 2022;4(3):e210318.

Eichhorn C, Greulich S, Bucciarelli-Ducci C, Sznitman R, Kwong RY, Gräni C. Multiparametric cardiovascular magnetic resonance approach in diagnosing, monitoring, and prognostication of myocarditis. Cardiovascular Imaging. 2022;15(7):1325-38.

Abbas AK, Fausto N, Robbins SL. Robbins and Cotran pathologic basis of disease: Elsevier Saunders; 2005.

Sechtem U, Tscholakoff D, Higgins C. MRI of the normal pericardium. American Journal of Roentgenology. 1986;147(2):239-44.

Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal. 2015;36(42):2921-64.

Oyama N, Oyama N, Komuro K, Nambu T, Manning WJ, Miyasaka K. Computed tomography and magnetic resonance imaging of the pericardium: anatomy and pathology. Magnetic Resonance in Medical Sciences. 2004;3(3):145-52.

Cosyns B, Plein S, Nihoyanopoulos P, Smiseth O, Achenbach S, Andrade MJ, et al. European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. European Heart Journal-Cardiovascular Imaging. 2015;16(1):12-31.

Al-Mallah M, Kwong RY. Assessing pericardial disease by CMR. Cardiovascular magnetic resonance imaging: Springer; 2008. p. 467-89.

Kovanlikaya A, Burke LP, Nelson MD, Wood J. Characterizing chronic pericarditis using steady-state free-precession cine MR imaging. American Journal of Roentgenology. 2002;179(2):475-6.

Taylor AM, Dymarkowski S, Verbeken EK, Bogaert J. Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results. European radiology. 2006;16:569-74.

Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. Journal of the American Society of Echocardiography. 2013;26(9):965-1012. e15.

Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, et al. A single breath‐hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2003;18(1):33-9.

Giorgi B, Mollet NR, Dymarkowski S, Rademakers FE, Bogaert J. Clinically suspected constrictive pericarditis: MR imaging assessment of ventricular septal motion and configuration in patients and healthy subjects. Radiology. 2003;228(2):417-24.

Groves R, Chan D, Zagurovskaya M, Teague SD. MR imaging evaluation of pericardial constriction. Magn Reson Imaging Clin N Am. 2015;23(1):81-7.

Masui T, Finck S, Higgins C. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology. 1992;182(2):369-73.

Thavendiranathan P, Verhaert D, Walls MC, Bender JA, Rajagopalan S, Chung Y-C, et al. Simultaneous right and left heart real-time, free-breathing CMR flow quantification identifies constrictive physiology. JACC: Cardiovascular Imaging. 2012;5(1):15-24.

de Faria AP, Silva TQA, Modolo R, Coelho-Filho OR. Advanced Imaging of Pericardial Diseases. Cardiovascular Magnetic Resonance Imaging. 2019:309-21.

Feng D, Glockner J, Kim K, Martinez M, Syed IS, Araoz P, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation. 2011;124(17):1830-7.

Zurick AO, Bolen MA, Kwon DH, Tan CD, Popovic ZB, Rajeswaran J, et al. Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC: Cardiovascular Imaging. 2011;4(11):1180-91.

Cremer PC, Tariq MU, Karwa A, Alraies MC, Benatti R, Schuster A, et al. Quantitative assessment of pericardial delayed hyperenhancement predicts clinical improvement in patients with constrictive pericarditis treated with anti-inflammatory therapy. Circulation: Cardiovascular Imaging. 2015;8(5):e003125.

Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases. Journal of Cardiovascular Magnetic Resonance. 2009;11(1):14.

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2021;43(7):561-632.

Bing R, Cavalcante JL, Everett RJ, Clavel M-A, Newby DE, Dweck MR. Imaging and impact of myocardial fibrosis in aortic stenosis. JACC: Cardiovascular Imaging. 2019;12(2):283-96.

Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Journal of the American College of Cardiology. 2010;55(23):2614-62.

von Knobelsdorff-Brenkenhoff F, Rudolph A, Wassmuth R, Bohl S, Buschmann EE, Abdel- Aty H, et al. Feasibility of cardiovascular magnetic resonance to assess the orifice area of aortic bioprostheses. Circulation: Cardiovascular Imaging. 2009;2(5):397-404.

Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation. 2009;119(3):468-78.

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014;63(22):e57-e185.

Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 2012;14(1):42.

Helvacioglu F, Yildirimturk O, Duran C, Yurdakul S, Tayyareci Y, Ulusoy OL, et al. The evaluation of mitral valve stenosis: comparison of transthoracic echocardiography and cardiac magnetic resonance. European Heart Journal–Cardiovascular Imaging. 2014;15(2):164-9.

Defrance C, Bollache E, Kachenoura N, Perdrix L, Hrynchyshyn N, Bruguière E, et al. Evaluation of aortic valve stenosis using cardiovascular magnetic resonance: comparison of an original semiautomated analysis of phase-contrast cardiovascular magnetic resonance with Doppler echocardiography. Circulation: Cardiovascular Imaging. 2012;5(5):604-12.

John AS, Dill T, Brandt RR, Rau M, Ricken W, Bachmann G, et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? Journal of the American College of Cardiology. 2003;42(3):519-26.

Kupfahl C, Honold M, Meinhardt G, Vogelsberg H, Wagner A, Mahrholdt H, et al. Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques. Heart. 2004;90(8):893-901.

Søndergaard L, Hildebrandt P, Lindvig K, Thomsen C, Stȧahlberg F, Kassis E, et al. Valve area and cardiac output in aortic stenosis: quantification by magnetic resonance velocity mapping. American heart journal. 1993;126(5):1156-64.

Barone-Rochette G, Piérard S, De Meester de Ravenstein C, Seldrum S, Melchior J, Maes F, et al. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. Journal of the American College of Cardiology. 2014;64(2):144-54.

Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99(13):932-7.

Koos R, Altiok E, Mahnken AH, Neizel M, Dohmen G, Marx N, et al. Evaluation of aortic root for definition of prosthesis size by magnetic resonance imaging and cardiac computed tomography: implications for transcatheter aortic valve implantation. International Journal of cardiology. 2012;158(3):353-8.

Ohyama H, Hosomi N, Takahashi T, Mizushige K, Osaka K, Kohno M, et al. Comparison of magnetic resonance imaging and transesophageal echocardiography in detection of thrombus in the left atrial appendage. Stroke. 2003;34(10):2436-9.

Debl K, Djavidani B, Buchner S, Heinicke N, Fredersdorf S, Haimerl J, et al. Assessment of the anatomic regurgitant orifice in aortic regurgitation: a clinical magnetic resonance imaging study. Heart. 2008;94(3):e8-e.

Buchner S, Poschenrieder F, Hamer OW, Jungbauer C, Resch M, Birner C, et al. Direct visualization of regurgitant orifice by CMR reveals differential asymmetry according to etiology of mitral regurgitation. JACC: Cardiovascular Imaging. 2011;4(10):1088-96.

Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circulation: Cardiovascular Imaging. 2013;6(1):48- 57.

Gabriel RS, Renapurkar R, Bolen MA, Verhaert D, Leiber M, Flamm SD, et al. Comparison of severity of aortic regurgitation by cardiovascular magnetic resonance versus transthoracic echocardiography. The American journal of cardiology. 2011;108(7):1014-20.

Rebergen SA, Chin J, Ottenkamp J, Van der Wall E, De Roos A. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation. 1993;88(5):2257-66.

Morris MF, Maleszewski JJ, Suri RM, Burkhart HM, Foley TA, Bonnichsen CR, et al. CT and MR imaging of the mitral valve: radiologic-pathologic correlation. Radiographics. 2010;30(6):1603-20.

Kizilbash AM, Hundley WG, Willett DL, Franco F, Peshock RM, Grayburn PA. Comparison of quantitative Doppler with magnetic resonance imaging for assessment of the severity of mitral regurgitation. American Journal of Cardiology. 1998;81(6):792-5.

Pype LL, Domenech-Ximenos B, Paelinck BP, Sturkenboom N, Van De Heyning CM. Assessment of Tricuspid Regurgitation by Cardiac Magnetic Resonance Imaging: Current Role and Future Applications. Journal of Clinical Medicine. 2024;13(15):4481.

Fogel MA, Pawlowski TW, Whitehead KK, Harris MA, Keller MS, Glatz AC, et al. Cardiac magnetic resonance and the need for routine cardiac catheterization in single ventricle patients prior to Fontan: a comparison of 3 groups: pre-Fontan CMR versus cath evaluation. Journal of the American College of Cardiology. 2012;60(12):1094-102.

Pomerantz BJ, Krock MD, Wollmuth JR, Cupps BP, Kouchoukos NT, Davila‐Roman VG, et al. Aortic valve replacement for aortic insufficiency: valve type as a determinant of systolic strain recovery. Journal of cardiac surgery. 2005;20(6):524-9.

Kvitting JP, Ebbers T, Wigström L, Engvall J, Olin CL, Bolger AF. Flow patterns in the aortic root and the aorta studied with time-resolved, 3-dimensional, phase-contrast magnetic resonance imaging: implications for aortic valve-sparing surgery. J Thorac Cardiovasc Surg. 2004;127(6):1602-7.

Galazka PZ, Kwong RY. Valvular Heart Disease Assessment by CMR. In: Kwong RY, Jerosch- Herold M, Heydari B, editors. Cardiovascular Magnetic Resonance Imaging. New York, NY: Springer New York; 2019. p. 323-37.

Motwani M, Kidambi A, Herzog BA, Uddin A, Greenwood JP, Plein S. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology. 2013;268(1):26-43.

Aghayev A, Steigner ML. CMR Assessment of Cardiac Masses. Cardiovascular Magnetic Resonance Imaging. 2019:273-307.

Fussen S, De Boeck BW, Zellweger MJ, Bremerich J, Goetschalckx K, Zuber M, et al. Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours. European heart journal. 2011;32(12):1551-60.

Hoffmann U, Globits S, Schima W, Loewe C, Puig S, Oberhuber G, et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. The American journal of cardiology. 2003;92(7):890-5.

Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, Resonance SfCM, et al. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. Journal of Cardiovascular Magnetic Resonance. 2013;15(1):91.

Bouton S, Yang A, McCrindle BW, Kidd L, McVeigh ER, Zerhouni EA. Differentiation of tumor from viable myocardium using cardiac tagging with MR imaging. Journal of computer assisted tomography. 1991;15(4):676-8.

Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma: a series of 112 consecutive cases. Medicine. 2001;80(3):159-72.

Reynen K. Cardiac myxomas. New England Journal of Medicine. 1995;333(24):1610-7.

Kuon E, Kreplin M, Weiss W, Dahm JB. The challenge presented by right atrial myxoma. Herz. 2004;29(7):702.

Burke AP, Virmani R. Cardiac myxoma: a clinicopathologic study. American journal of clinical pathology. 1993;100(6):671-80.

Bjessmo S, Torbjörn Ivert M. Cardiac myxoma: 40 years’ experience in 63 patients. The Annals of thoracic surgery. 1997;63(3):697-700.

Pucci A, Gagliardotto P, Zanini C, Pansini S, di Summa M, Mollo F. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. American heart journal. 2000;140(1):134-8.

TAZELAAR HD, LOCKE TJ, McGREGOR CG, editors. Pathology of surgically excised primary cardiac tumors. Mayo Clinic Proceedings; 1992: Elsevier.

McCarthy PM, Piehler JM, Schaff HV, Pluth JR, Orszulak TA, Vidaillet HJ, et al. The significance of multiple, recurrent, and “complex” cardiac myxomas. The Journal of Thoracic and Cardiovascular Surgery. 1986;91(3):389-96.

Colin G, Dymarkowski S, Gerber B, Michoux N, Bogaert J. Cardiac myxoma imaging features and tissue characteristics at cardiovascular magnetic resonance. International journal of cardiology. 2016;202:950-1.

Colin GC, Gerber BL, Amzulescu M, Bogaert J. Cardiac myxoma: a contemporary multimodality imaging review. The International Journal of Cardiovascular Imaging. 2018;34(11):1789-808.

Caspar T, El Ghannudi S, Ohana M, Labani A, Lawson A, Ohlmann P, et al. Magnetic resonance evaluation of cardiac thrombi and masses by T1 and T2 mapping: an observational study. The International Journal of Cardiovascular Imaging. 2017;33:551-9.

Bauner K, Sourbron S, Picciolo M, Schmitz C, Theisen D, Sandner T, et al. MR first pass perfusion of benign and malignant cardiac tumours—significant differences and diagnostic accuracy. European radiology. 2012;22:73-82.

Hananouchi GI, Goff II WB. Cardiac lipoma: six-year follow-up with MRI characteristics, and a review of the literature. Magnetic resonance imaging. 1990;8(6):825-8.

King S, Smallhorn J, Burrows P. Epicardial lipoma: imaging findings. AJR American journal of roentgenology. 1993;160(2):261-2.

Doshi S, Halim M, Singh H, Patel R. Massive intrapericardial lipoma, a rare cause of breathlessness. Investigations and management. International journal of cardiology. 1998;66(2):211-5.

Akram K, Hill C, Neelagaru N, Parker M. A left ventricular lipoma presenting as heart failure in a septuagenarian: a first case report. International journal of cardiology. 2007;114(3):386-7.

Grande A, Minzioni G, Pederzolli C, Rinaldi M. Cardiac lipomas: description of 3 cases. Journal of Cardiovascular Surgery. 1998;39(6):813.

Vanderheyden M, De Sutter J, Wellens F, Andries E. Left atrial lipoma: case report and review of the literature. Acta cardiologica. 1998;53(1):31-2.

Araoz PA, Mulvagh SL, Tazelaar HD, Julsrud PR, Breen JF. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000;20(5):1303- 19.

Howard RA, Aldea GS, Shapira OM, Kasznica JM, Davidoff R. Papillary fibroelastoma: increasing recognition of a surgical disease. The Annals of thoracic surgery. 1999;68(5):1881-5.

Scalia D, Basso C, Rizzoli G, Lupia M, Budano S, Thiene G, et al. Should right-sided fibroelastomas be operated upon? The Journal of heart valve disease. 1997;6(6):647-50.

Kumar G, MacDonald RJ, Sorajja P, Edwards WD, Ommen SR, Klarich KW. Papillary fibroelastomas in 19 patients with hypertrophic cardiomyopathy undergoing septal myectomy. Journal of the American Society of Echocardiography. 2010;23(6):595-8.

Aggarwal A, Leavitt BJ. Giant lambl's excrescences. New England Journal of Medicine. 2003;349(25):e24.

Edwards FH, Hale D, Cohen A, Thompson L, Pezzella AT, Virmani R. Primary cardiac valve tumors. The Annals of thoracic surgery. 1991;52(5):1127-31.

Sun JP, Asher CR, Yang XS, Cheng GG, Scalia GM, Massed AG, et al. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation. 2001;103(22):2687-93.

Kondruweit M, Schmid M, Strecker T. Papillary fibroelastoma of the mitral valve: appearance in 64-slice spiral computed tomography, magnetic resonance imaging, and echocardiography. European heart journal. 2008;29(6):831-.

Kelle S, Chiribiri A, Meyer R, Fleck E, Nagel E. Papillary fibroelastoma of the tricuspid valve seen on magnetic resonance imaging. Circulation. 2008;117(11):e190-e1.

Koçak H, Özyazıcıoğlu A, Gündoğdu C, Sevimli S. Cardiac hemangioma complicated with cerebral and coronary embolization. Heart and Vessels. 2005;20:296-7.

Eftychiou C, Antoniades L. Cardiac hemangioma in the left ventricle and brief review of the literature. Journal of Cardiovascular Medicine. 2009;10(7):565-7.

McManus B. Primary tumors of the heart. Braunwald's heart disease: a textbook of cardiovascular medicine. 2012:1638-50.

Burke A. Tumors of the heart and great vessels. Atlas of tumor pathology 3rd Series 1st ed/American Registry of Pathology. 1996.

Oshima H, Hara M, Kono T, Shibamoto Y, Mishima A, Akita S. Cardiac hemangioma of the left atrial appendage: CT and MR findings. Journal of thoracic imaging. 2003;18(3):204-6.

Patel J, Patel S, Sheppard MN. Benign cardiac tumours associated with sudden death. Europace. 2014;16(6):855-60.

Burke AP, Rosado-de-Christenson M, Templeton PA, Virmani R. Cardiac fibroma: clinicopathologic correlates and surgical treatment. The Journal of Thoracic and Cardiovascular Surgery. 1994;108(5):862-70.

Herman T, Siegel M, McAlister W. Cardiac tumor in Gorlin syndrome: Nevoid basal cell carcinoma syndrome. Pediatric radiology. 1991;21:234-5.

Goel S, Chen O, Brichkov I, Lipton J, Seemanthini L, Shani J. Asymptomatic giant cardiac fibroma presenting as mitral valve prolapse in an adult patient. The International Journal of Cardiovascular Imaging. 2015;31:315-7.

Luna A, Ribes R, Caro P, Vida J, Erasmus JJ. Evaluation of cardiac tumors with magnetic resonance imaging. European radiology. 2005;15:1446-55.

Sparrow PJ, Kurian JB, Jones TR, Sivananthan MU. MR imaging of cardiac tumors. Radiographics. 2005;25(5):1255-76.

Kiaffas MG, Powell AJ, Geva T. Magnetic resonance imaging evaluation of cardiac tumor characteristics in infants and children. American Journal of Cardiology. 2002;89(10):1229-33.

Gow RM, Haney I, Mawson J, Williams WG, Freedom RM. Pediatric primary benign cardiac tumors: a 15-year review. American heart journal. 1997;134(6):1107-14.

Krasuski RA, Hesselson AB, Landolfo KP, Ellington KJ, Bashore TM. Cardiac rhabdomyoma in an adult patient presenting with ventricular arrhythmia. Chest. 2000;118(4):1217-21.

Chen X, Hoda SA, Edgar MA. Cardiac rhabdomyoma. Archives of pathology & laboratory medicine. 2002;126(12):1559-.

Berkenblit R, Spindola-Franco H, Frater RW, Fish BB, Glickstein JS. MRI in the evaluation and management of a newborn infant with cardiac rhabdomyoma. The Annals of thoracic surgery. 1997;63(5):1475-7.

Fieno DS, Saouaf R, Thomson LE, Abidov A, Friedman JD, Berman DS. Cardiovascular magnetic resonance of primary tumors of the heart: a review. Journal of Cardiovascular Magnetic Resonance. 2006;8(6):839-53.

Lin JC, Palafox BA, Jackson HA, Cohen AJ, Gazzaniga AB. Cardiac pheochromocytoma: resection after diagnosis by 111-indium octreotide scan. The Annals of thoracic surgery. 1999;67(2):555-8.

Hamilton BH, Francis IR, Gross BH, Korobkin M, Shapiro B, Shulkin B, et al. Intrapericardial paragangliomas (pheochromocytomas): imaging features. AJR American journal of roentgenology. 1997;168(1):109-13.

Orenstein H, Green G, Kancherla P. Aortocoronary paraganglioma. Anatomic relationship of left coronary artery to paraganglia of aorta. New York state journal of medicine. 1984;84(1):33- 6.

Cane ME, Berrizbeitia LD, Yang SS, Mahapatro D, McGrath LB. Paraganglioma of the interatrial septum. The Annals of thoracic surgery. 1996;61(6):1845-7.

Buckley O, Madan R, Kwong R, Rybicki FJ, Hunsaker A. Cardiac masses, part 2: key imaging features for diagnosis and surgical planning. American Journal of Roentgenology. 2011;197(5):W842-W51.

Tomasian A, Lai C, Ruehm S, Krishnam MS. Cardiovascular magnetic resonance and PET- CT of left atrial paraganglioma. Journal of Cardiovascular Magnetic Resonance. 2010;12:1-4.

Burke A, Anderson PG, Virmani R, James TN, Herrera G, Ceballos R. Tumor of the atrioventricular nodal region. Arch Pathol Lab Med. 1990;114:1057-62.

Sharma G, Linden MD, Schultz DS, Inamdar KV. Cystic tumor of the atrioventricular node: an unexpected finding in an explanted heart. Cardiovascular Pathology. 2010;19(3):e75-e8.

Wolf PL, Bing R. The smallest tumor which causes sudden death. Jama. 1965;194(6):674- 5.

Guo J, Zuo S, Lin C, Ji Y. Surgical treatment of a giant cystic tumor of the atrioventricular nodal region. Interactive CardioVascular and Thoracic Surgery. 2009;8(5):592-3.

Strøm E, Skjørten F, Stokke E. Polycystic tumor of the atrioventricular nodal region in a man with Emery-Dreifuss muscular dystrophy. Pathology-Research and Practice. 1993;189(8):960-4.

Law KB, Feng T, Nair V, Cusimano RJ, Butany J. Cystic tumor of the atrioventricular node: rare antemortem diagnosis. Cardiovascular Pathology. 2012;21(2):120-7.

Randhawa K, Ganeshan A, Hoey ET. Magnetic resonance imaging of cardiac tumors: part 1, sequences, protocols, and benign tumors. Current problems in diagnostic radiology. 2011;40(4):158-68.

Tran TT, Starnes V, Wang X, Getzen J, Ross BD. Cardiovascular magnetic resonance diagnosis of cystic tumor of the atrioventricular node. Journal of Cardiovascular Magnetic Resonance. 2009;11:1-4.

Kaji T, Takamatsu H, Noguchi H, Tahara H, Matsuda H, Nomura Y, et al. Cardiac lymphangioma: case report and review of the literature. Journal of Pediatric Surgery. 2002;37(10):1-3.

Huang Z. Lymphangioma of the left ventricle. Journal of Cardiac Surgery: Including Mechanical and Biological Support for the Heart and Lungs. 2013;28(1):24-5.

Syed IS, Feng D, Harris SR, Martinez MW, Misselt AJ, Breen JF, et al. MR imaging of cardiac masses. Magnetic resonance imaging clinics of North America. 2008;16(2):137-64.

Pennec P-Y, Blanc J-J. Cardiac lymphangioma: a benign cardiac tumour. European heart journal. 2006;27(24):2913-.

Reynen K. Frequency of primary tumors of the heart. The American journal of cardiology. 1996;77(1):107.

Van Beek EJ, Stolpen AH, Khanna G, Thompson BH. CT and MRI of pericardial and cardiac neoplastic disease. Cancer Imaging. 2007;7(1):19.

Look Hong NJ, Pandalai PK, Hornick JL, Shekar PS, Harmon DC, Chen Y-L, et al. Cardiac angiosarcoma management and outcomes: 20-year single-institution experience. Annals of surgical oncology. 2012;19:2707-15.

Afzal MN, Alguacil-Garcia A. Primary cardiac angiosarcoma: clinical and pathological diagnostic problems. The Canadian journal of cardiology. 1997;13(3):293-6.

Herrmann MA, Shankerman RA, Edwards WD, Shub C, Schaff HV. Primary cardiac angiosarcoma: a clinicopathologic study of six cases. The Journal of Thoracic and Cardiovascular Surgery. 1992;103(4):655-64.

Araoz PA, Eklund HE, Welch TJ, Breen JF. CT and MR imaging of primary cardiac malignancies. Radiographics. 1999;19(6):1421-34.

Rodrigues AG, Tardif J-C, Petitclerc R, Mercier L-A, Paquet E, Leung TK, et al. Angiosarcomas of the interatrial septum mimicking atrial myxomas. Journal of the American Society of Echocardiography. 1996;9(2):209-12.

Puppala S, Hoey ETD, Mankad K, Wood A. Primary cardiac angiosarcoma arising from the interatrial septum: magnetic resonance imaging appearances. The British Journal of Radiology. 2010;83(995):e230-e4.

Chaturvedi A, Vummidi D, Shuman WP, Dubinsky TJ, Maki JH. Cardiac angiosarcoma: an unusual cause of coronary artery pseudoaneurysm. Journal of Thoracic Imaging. 2012;27(1):W8- W9.

Valeviciene N, Mataciunas M, Tamosiunas A, Petrulioniene Z, Briediene R. Primary heart angiosarcoma detected by magnetic resonance imaging. Acta Radiologica. 2006;47(7):675-9.

Deetjen AG, Conradi G, Möllmann S, Hamm CW, Dill T. Cardiac angiosarcoma diagnosed and characterized by cardiac magnetic resonance imaging. Cardiology in review. 2006;14(2):101- 3.

Akkaya Z, Gursoy A, Erden A. The disastrous “sun ray” sign in cardiac magnetic resonance: an indicator of angiosarcoma. Cardiology in the Young. 2014;24(5):929-31.

Burke AP, Cowan D, Virmani R. Primary sarcomas of the heart. Cancer. 1992;69(2):387-95.

Donsbeck, Ranchere, Coindre, Gall L, Cordier, Loire. Primary cardiac sarcomas: an immunohistochemical and grading study with long‐term follow‐up of 24 cases. Histopathology. 1999;34(4):295-304.

Itoh K, Matsumura T, Egawa Y, Watanabe M, Ohshio T, Ohta A, et al. Primary mitral valve sarcoma in infancy. Pediatric cardiology. 1998;19:174-7.

Bi W, Qu R, Ren W. A primary pericardial undifferentiated sarcoma invading the right atrium and superior vena cava. Echocardiography. 2012;29(8):E182-E5.

Castorino F, Masiello P, Quattrocchi E, Di Benedetto G. Primary cardiac rhabdomyosarcoma of the left atrium: an unusual presentation. Texas Heart Institute Journal. 2000;27(2):206.

Hui KS, Green L, Schmidt W. Primary cardiac rhabdomyosarcoma: definition of a rare entity. The American Journal of Cardiovascular Pathology. 1988;2(1):19-29.

Lo Re III V, Fox KR, Ferrari VA, Scott CH, Kossev PM, Kostman JR. Hypereosinophilia associated with cardiac rhabdomyosarcoma. American journal of hematology. 2003;74(1):64-7.

Raaf HN, Raaf JH, editors. Sarcomas related to the heart and vasculature. Seminars in Surgical Oncology; 1994: Wiley Online Library.

Vujin B, Benc D, Srdic S, Bikicki M, Vuckovic D, Dodic S. Rhabdomyosarcoma of the heart. Herz. 2006;31(8):798.

Dohi T, Ohmura H, Daida H, Amano A. Primary right atrial cardiac osteosarcoma with congestive heart failure. European journal of cardio-thoracic surgery. 2009;35(3):544-6.

Sogabe O, Ohya T. Right ventricular failure due to primary right ventricle osteosarcoma. General thoracic and cardiovascular surgery. 2007;55:19-22.

Hashimoto W, Hashizume K, Ariyoshi T, Taniguchi S, Miura T, Kinoshita N, et al. Primary cardiac osteosarcoma with imaging that revealed no calcification. General thoracic and cardiovascular surgery. 2011;59:184-6.

Bradford WT, Arora H, Sheridan BC, Sileshi B, Kumar PA. A left atrial mass in a middle-aged woman: just another myxoma? Journal of Cardiothoracic and Vascular Anesthesia. 2013;27(4):816-8.

Burke AP, Virmani R. Osteosarcomas of the heart. The American Journal of Surgical Pathology. 1991;15(3):289-95.

Gomez-Rubin MC, Rios JCS, Dobarro D, Sanchez-Recalde A, Bret-Zurita M, Filgueiras D, et al. A recidivant primary cardiac osteosarcoma: the role of bone scans. Cardiovascular Pathology. 2010;19(1):55-8.

Ahn S, Choi J-A, Chung J-H, Choi H, Chun EJ, Choi SI, et al. MR imaging findings of a primary cardiac osteosarcoma and its bone metastasis with histopathologic correlation. Korean Journal of Radiology. 2011;12(1):135-9.

Clarke N, Mohiaddin R, Westaby S, Banning A. Multifocal cardiac leiomyosarcoma. Diagnosis and surveillance by transoesophageal echocardiography and contrast enhanced cardiovascular magnetic resonance. Postgraduate medical journal. 2002;78(922):492-3.

Willaert W, Claessens P, Vanderheyden M. Leiomyosarcoma of the right ventricle extending into the pulmonary trunk. Heart. 2001;86(1):e2-e.

Lo F-L, Chou Y-H, Tiu C-M, Lan G-Y, Hwang J-H, Chern M-S, et al. Primary cardiac leiomyosarcoma: imaging with 2-D echocardiography, electron beam CT and 1.5-Tesla MR. European journal of radiology. 1998;27(1):72-6.

Jellis C, Doyle J, Sutherland T, Gutman J, MacIsaac A. Cardiac epithelioid leiomyosarcoma and the role of cardiac imaging in the differentiation of intracardiac masses. Clinical Cardiology. 2010;33(6):E6-E9.

Knobel B, Rosman P, Kishon Y, Husar M. Intracardiac primary fibrosarcoma. Case report and literature review. The Thoracic and Cardiovascular Surgeon. 1992;40(04):227-30.

Hoffstetter P, Djavidani B, Feuerbach S, Hofstädter F, Seitz J. Myxoid fibrosarcoma of a pulmonary vein with extension into the left atrium. American Journal of Roentgenology. 2006;186(2):365-7.

Paraf F, Bruneval P, Balaton A, Deloche A, Mikol J, Maitre F, et al. Primary liposarcoma of the heart. The American Journal of Cardiovascular Pathology. 1990;3(2):175-80.

Wu TP, Zhou F, DeAnda Jr A, Melamed J, Lim RP, Balsam LB. Surgical management of cardiac liposarcomas. Journal of Cardiac Surgery. 2012;27(2):192-5.

Hoey E, Mankad K, Puppala S, Gopalan D, Sivananthan M. MRI and CT appearances of cardiac tumours in adults. Clinical radiology. 2009;64(12):1214-30.

Wang J-G, Li N-N. Primary cardiac synovial sarcoma. The Annals of Thoracic Surgery. 2013;95(6):2202-9.

Kim CH, Dancer JY, Coffey D, Zhai QJ, Reardon M, Ayala AG, et al. Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10-year single institution experience. Human pathology. 2008;39(6):933-8.

Zargouni N, Mrad K, Cammoun M, Romdhane B. Primary synovial sarcoma of the heart. A clinicopathologic study of one case and review of the literature. Pathologica. 2004;96(1):29-34.

Lv X, Guo X, Chen X, He Z, Shen J, Jin T, et al. Primary cardiac synovial sarcoma. Journal of Cardiac Surgery. 2010;25(3):288-90.

Wolf M, Van den Brande J, Rodrigus I, Paelinck BP. Giant primary right ventricular synovial sarcoma. European Heart Journal. 2014;35(37):2509-.

Ceresoli GL, Ferreri AJ, Bucci E, Ripa C, Ponzoni M, Villa E. Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1997;80(8):1497-506.

Rockwell L, Hetzel P, Freeman JK, Fereshetian A. Cardiac involvement in malignancies: CASE 3. Primary cardiac lymphoma. Journal of clinical oncology. 2004;22(13):2744-5.

Nelson KH, Chatzizisis YS, Steigner ML, Mitchell RN, Blankstein R, Givertz MM. Cardiac allograft involvement by post-transplantation lymphoproliferative disorder. Journal of the American College of Cardiology. 2013;62(10):937-.

113

Engelen MA, Juergens KU, Breithardt G, Eckardt L. Interatrial conduction delay and atrioventricular block due to primary cardiac lymphoma. Journal of cardiovascular electrophysiology. 2005;16(8).

Anghel G, Zoli V, Petti N, Remotti D, Feccia M, Pino P, et al. Primary cardiac lymphoma: report of two cases occurring in immunocompetent subjects. Leukemia & lymphoma. 2004;45(4):781-8.

Ciancarella P, Fusco A, Citraro D, Sperandio M, Floris R. Multimodality imaging evaluation of a primary cardiac lymphoma. J Saudi Heart Assoc. 2017;29(2):128-35.

Abraham K, Reddy V, Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. The American journal of cardiovascular pathology. 1990;3(3):195-8.

Klatt EC, Heitz DR. Cardiac metastases. Cancer. 1990;65(6):1456-9.

Tas F, Mudun A, Kirma C. Cardiac involvement in melanoma: a case report and review of the literature. Journal of Cancer Research and Therapeutics. 2010;6(3):359-61.

Weiss L. An analysis of the incidence of myocardial metastasis from solid cancers. Heart. 1992;68(11):501-4.

Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. Journal of clinical pathology. 2007;60(1):27-34.

Mousseaux E, Meunier P, Azancott S, Dubayle P, Gaux J-C. Cardiac metastatic melanoma investigated by magnetic resonance imaging. Magnetic resonance imaging. 1998;16(1):91-5.

Vogel-Claussen J, Rochitte CE, Wu KC, Kamel IR, Foo TK, Lima JA, et al. Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics. 2006;26(3):795-810.

Weinsaft JW, Kim HW, Shah DJ, Klem I, Crowley AL, Brosnan R, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance: prevalence and markers in patients with systolic dysfunction. Journal of the American College of Cardiology. 2008;52(2):148-57.

Pazos-López P, Pozo E, Siqueira ME, García-Lunar I, Cham M, Jacobi A, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC: Cardiovascular Imaging. 2014;7(9):896- 905.

Paydarfar D, Krieger D, Dib N, Blair RH, Pastore JO, Stetz Jr JJ, et al. In vivo magnetic resonance imaging and surgical histopathology of intracardiac masses: distinct features of subacute thrombi. Cardiology. 2001;95(1):40-7.

Corti R, Osende JI, Fayad ZA, Fallon JT, Fuster V, Mizsei G, et al. In vivo noninvasive detection and age definition of arterial thrombus by MRI. Journal of the American College of Cardiology. 2002;39(8):1366-73.

Barkhausen J, Hunold P, Eggebrecht H, Schüler WO, Sabin GV, Erbel R, et al. Detection and characterization of intracardiac thrombi on MR imaging. American Journal of Roentgenology. 2002;179(6):1539-44.

Mollet NR, Dymarkowski S, Volders W, Wathiong J, Herbots L, Rademakers FE, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation. 2002;106(23):2873-6.

Baumgartner H, De Backer J, Babu-Narayan S, Budts W, Chessa M, Diller G-P, et al. 2020 ESC guidelines for themanagement of adult congenital heart disease. Российский кардиологический журнал. 2021(9):330-422.

Moscatelli S, Pozza A, Leo I, Ielapi J, Scatteia A, Piana S, et al. Importance of Cardiovascular magnetic resonance Applied to congenital Heart diseases in Pediatric Age: a narrative review. Children. 2024;11(7):878.

Fogel MA, Anwar S, Broberg C, Browne L, Chung T, Johnson T, et al. Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association. Circulation: Cardiovascular Imaging. 2022;15(6):e014415.

Secinaro A, Ait-Ali L, Curione D, Clemente A, Gaeta A, Giovagnoni A, et al. Recommendations for cardiovascular magnetic resonance and computed tomography in congenital heart disease: A consensus paper from the CMR/CCT working group of the Italian Society of Pediatric Cardiology (SICP) and the Italian College of Cardiac Radiology endorsed by the Italian Society of Medical and Interventional Radiology (SIRM) Part I. La radiologia medica. 2022;127(7):788-802.

Ntsinjana HN, Tann O, Hughes M, Derrick G, Secinaro A, Schievano S, et al. Utility of adenosine stress perfusion CMR to assess paediatric coronary artery disease. European Heart Journal-Cardiovascular Imaging. 2017;18(8):898-905.

Isorni M-A, Moisson L, Moussa NB, Monnot S, Raimondi F, Roussin R, et al. 4D flow cardiac magnetic resonance in children and adults with congenital heart disease: Clinical experience in a high volume center. International Journal of Cardiology. 2020;320:168-77.

Bissell MM, Raimondi F, Ali LA, Allen BD, Barker AJ, Bolger A, et al. 4D Flow cardiovascular magnetic resonance consensus statement: 2023 update. Journal of Cardiovascular Magnetic Resonance. 2023;25(1):40.

Pushparajah K. Non-invasive imaging in the evaluation of cardiac shunts for interventional closure. Frontiers in Cardiovascular Medicine. 2021;8:651726.

Scatteia A, Silverio A, Padalino R, De Stefano F, America R, Cappelletti AM, et al. Non- invasive assessment of left ventricle ejection fraction: where do we stand? Journal of Personalized Medicine. 2021;11(11):1153.

Cavalcante JL, Lalude OO, Schoenhagen P, Lerakis S. Cardiovascular magnetic resonance imaging for structural and valvular heart disease interventions. JACC: Cardiovascular Interventions. 2016;9(5):399-425.

Bonnemains L, Raimondi F, Odille F. Specifics of cardiac magnetic resonance imaging in children. Archives of cardiovascular diseases. 2016;109(2):143-9.

Craig B. Atrioventricular septal defect: from fetus to adult. Heart. 2006;92(12):1879-85.

Calkoen EE, Westenberg JJ, Kroft LJ, Blom NA, Hazekamp MG, Rijlaarsdam ME, et al. Characterization and quantification of dynamic eccentric regurgitation of the left atrioventricular valve after atrioventricular septal defect correction with 4D Flow cardiovascular magnetic resonance and retrospective valve tracking. Journal of Cardiovascular Magnetic Resonance. 2015;17(1):18.

Broadhouse KM, Price AN, Durighel G, Cox DJ, Finnemore AE, Edwards AD, et al. Assessment of PDA shunt and systemic blood flow in newborns using cardiac MRI. NMR in Biomedicine. 2013;26(9):1135-41.

Dorfman AL, Geva T. Magnetic resonance imaging evaluation of congenital heart disease: conotruncal anomalies. Journal of Cardiovascular Magnetic Resonance. 2006;8(4):645-59.

Harris MA, Avitabile CM, Fu GL, Kim DW, Kim TS, Gillespie MJ, et al. Accuracy and internal consistency of cardiac magnetic resonance imaging in measuring branch pulmonary artery flows in patients with conotruncal anomalies and branch pulmonary artery stents. The American Journal of Cardiology. 2016;117(7):1160-6.

Frank L, Dillman JR, Parish V, Mueller GC, Kazerooni EA, Bell A, et al. Cardiovascular MR imaging of conotruncal anomalies. Radiographics. 2010;30(4):1069-94.

Prakash A, Geva T. Magnetic Resonance Imaging Evaluation of Complex Congenital Heart Disease. Cardiovascular Magnetic Resonance Imaging. 2019:339-57.

Moscatelli S, Avesani M, Borrelli N, Sabatino J, Pergola V, Leo I, et al. Complete transposition of the great arteries in the pediatric field: a multimodality imaging approach. Children. 2024;11(6):626.

Di Salvo G, Miller O, Babu Narayan S, Li W, Budts W, Valsangiacomo Buechel ER, et al. Imaging the adult with congenital heart disease: a multimodality imaging approach—position paper from the EACVI. European Heart Journal-Cardiovascular Imaging. 2018;19(10):1077-98.

Grothoff M, Fleischer A, Abdul-Khaliq H, Hoffmann J, Lehmkuhl L, Luecke C, et al. The systemic right ventricle in congenitally corrected transposition of the great arteries is different

from the right ventricle in dextro-transposition after atrial switch: a cardiac magnetic resonance study. Cardiology in the Young. 2013;23(2):239-47.

DiLorenzo MP, Grosse-Wortmann L. Myocardial Fibrosis in Congenital Heart Disease and the Role of MRI. Radiology: Cardiothoracic Imaging. 2023;5(3):e220255.

Cheung Y-f, Lam WW, So EK, Chow P-c. Differential myocardial fibrosis of the systemic right ventricle and subpulmonary left ventricle after atrial switch operation for complete transposition of the great arteries. IJC Heart & Vasculature. 2020;30:100612.

Rizk J. 4D flow MRI applications in congenital heart disease. European Radiology. 2021;31:1160-74.

Canan A, Ashwath R, Agarwal PP, François C, Rajiah P. Multimodality imaging of transposition of the great arteries. Radiographics. 2021;41(2):338-60.

Shiina Y, Inai K, Takahashi T, Taniguchi K, Watanabe E, Fukushima K, et al. Inter-and intra- ventricular dyssynchrony in the systemic right ventricle is a surrogate marker of major cardiac events in mildly symptomatic patients. Heart and Vessels. 2018;33:1086-93.

Santens B, Helsen F, Van De Bruaene A, De Meester P, Budts A-L, Troost E, et al. Adverse functional remodelling of the subpulmonary left ventricle in patients with a systemic right ventricle is associated with clinical outcome. European Heart Journal-Cardiovascular Imaging. 2022;23(5):680-8.

Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER, et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. Journal of Cardiovascular Magnetic Resonance. 2013;15:1-26.

Van Wijk W, Breur J, Westenberg J, Driessen M, Meijboom F, Driesen B, et al. Validation of aortic valve 4D flow analysis and myocardial deformation by cardiovascular magnetic resonance in patients after the arterial switch operation. Journal of Cardiovascular Magnetic Resonance. 2019;21:1-10.

Huang ES, Herrmann JL, Rodefeld MD, Turrentine MW, Brown JW. Rastelli operation for D- transposition of the great arteries, ventricular septal defect, and pulmonary stenosis. World Journal for Pediatric and Congenital Heart Surgery. 2019;10(2):157-63.

Silversides CK, Roche SL. Congenitally corrected transposition of the great arteries: untangling the mechanisms of right ventricular dysfunction. American College of Cardiology Foundation Washington DC; 2022. p. 575-7.

Kumar TS. Congenitally corrected transposition of the great arteries. Journal of thoracic disease. 2020;12(3):1213.

Kawakubo M, Nagao M, Ishizaki U, Shiina Y, Inai K, Yamasaki Y, et al. Feature-tracking MRI fractal analysis of right ventricular remodeling in adults with congenitally corrected transposition of the great arteries. Radiology: Cardiothoracic Imaging. 2019;1(4):e190026.

Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, Gatzoulis MA, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014;100(3):247-53.

Kilner PJ, Geva T, Kaemmerer H, Trindade PT, Schwitter J, Webb GD. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. European heart journal. 2010;31(7):794- 805.

Valente AM, Cook S, Festa P, Ko HH, Krishnamurthy R, Taylor AM, et al. Multimodality imaging guidelines for patients with repaired tetralogy of Fallot: a report from the American Society of Echocardiography: developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society for Pediatric Radiology. Journal of the American Society of Echocardiography. 2014;27(2):111-41.

Lapierre C, Dubois J, Rypens F, Raboisson M-J, Déry J. Tetralogy of Fallot: preoperative assessment with MR and CT imaging. Diagnostic and Interventional Imaging. 2016;97(5):531-41.

Apostolopoulou SC, Manginas A, Kelekis NL, Noutsias M. Cardiovascular imaging approach in pre and postoperative tetralogy of Fallot. BMC cardiovascular disorders. 2019;19(1):7.

Ojha V, Pandey NN, Sharma A, Ganga KP. Spectrum of changes on cardiac magnetic resonance in repaired tetralogy of Fallot: Imaging according to surgical considerations. Clinical imaging. 2021;69:102-14.

Elsayed A, Gilbert K, Scadeng M, Cowan BR, Pushparajah K, Young AA. Four-dimensional flow cardiovascular magnetic resonance in tetralogy of Fallot: a systematic review. Journal of Cardiovascular Magnetic Resonance. 2021;23(1):59.

Kozak MF, Redington A, Yoo S-J, Seed M, Greiser A, Grosse-Wortmann L. Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study. Pediatric radiology. 2014;44:403-9.

Koppel CJ, Jongbloed MR, Kies P, Hazekamp MG, Mertens BJ, Schalij MJ, et al. Coronary anomalies in tetralogy of Fallot–A meta-analysis. International Journal of Cardiology. 2020;306:78-85.

Wang Z, Li Z. Long-term results of biventricular correction for patients with double outlet right ventricle. Cardiology in the Young. 2023;33(8):1367-77.

Xu Z, Semple T, Gu H, McCarthy KP, Ho SY, Li W. Double outlet ventricles: review of anatomic and imaging characteristics. Heart. 2023;109(12):905-12.

Karev E, Stovpyuk OF. Double outlet right ventricle in adults: Anatomic variability, surgical treatment, and late postoperative complications. Journal of Clinical Ultrasound. 2022;50(8):1151-65.

Loke Y-H, Gupta SK, Mandell J, Schidlow D, Wernovsky G, Olivieri L. Congenital heart disease illustrated: use of cross-sectional imaging in pediatric cardiology. Journal of Thoracic Imaging. 2024;39(1):34-46.

Ryd D, Fricke K, Bhat M, Arheden H, Liuba P, Hedström E. Utility of fetal cardiovascular magnetic resonance for prenatal diagnosis of complex congenital heart defects. JAMA network open. 2021;4(3):e213538-e.

Lloyd DF, Van Poppel MP, Pushparajah K, Vigneswaran TV, Zidere V, Steinweg J, et al. Analysis of 3-dimensional arch anatomy, vascular flow, and postnatal outcome in cases of suspected coarctation of the aorta using fetal cardiac magnetic resonance imaging. Circulation: Cardiovascular Imaging. 2021;14(7):e012411.

Leo I, Sabatino J, Avesani M, Moscatelli S, Bianco F, Borrelli N, et al. Non-invasive imaging assessment in patients with aortic coarctation: a contemporary review. Journal of Clinical Medicine. 2023;13(1):28.

Nussbaumer C, Bouchardy J, Blanche C, Piccini D, Pavon A-G, Monney P, et al. 2D cine vs. 3D self-navigated free-breathing high-resolution whole heart cardiovascular magnetic resonance for aortic root measurements in congenital heart disease. Journal of Cardiovascular Magnetic Resonance. 2021;23(1):65.

Doyle CM, Orr J, Greenwood JP, Plein S, Tsoumpas C, Bissell MM. Four‐dimensional flow magnetic resonance imaging in the assessment of blood flow in the heart and great vessels: A systematic review. Journal of Magnetic Resonance Imaging. 2022;55(5):1301-21.

Quail MA, Segers P, Steeden JA, Muthurangu V. The aorta after coarctation repair–effects of calibre and curvature on arterial haemodynamics. Journal of Cardiovascular Magnetic Resonance. 2019;21(1):22.

McHugh KE, Hillman DG, Gurka MJ, Gutgesell HP. Three‐stage Palliation of Hypoplastic Left Heart Syndrome in the University HealthSystem Consortium. Congenital heart disease. 2010;5(1):8-15.

Muthurangu V, Taylor AM, Hegde SR, Johnson R, Tulloh R, Simpson JM, et al. Cardiac magnetic resonance imaging after stage I Norwood operation for hypoplastic left heart syndrome. Circulation. 2005;112(21):3256-63.

Harris MA, Cosulich MT, Gillespie MJ, Whitehead KK, Liu TI, Weinberg PM, et al. Pre-Fontan cardiac magnetic resonance predicts post-Fontan length of stay and avoids ionizing radiation. The Journal of Thoracic and Cardiovascular Surgery. 2009;138(4):941-7.

Banka P, McElhinney DB, Bacha EA, Mayer JE, Gauvreau K, Geva T, et al. What is the clinical utility of routine cardiac catheterization before a Fontan operation? Pediatric cardiology. 2010;31:977-85.

Moscatelli S, Borrelli N, Sabatino J, Leo I, Avesani M, Montanaro C, et al. Role of cardiovascular imaging in the follow-up of patients with Fontan circulation. Children. 2022;9(12):1875.

Meyer SL, St. Clair N, Powell AJ, Geva T, Rathod RH. Integrated clinical and magnetic resonance imaging assessments late after Fontan operation. Journal of the American College of Cardiology. 2021;77(20):2480-9.

Puricelli F, Voges I, Gatehouse P, Rigby M, Izgi C, Pennell DJ, et al. Performance of cardiac MRI in pediatric and adult patients with fontan circulation. Radiology: Cardiothoracic Imaging. 2022;4(3):e210235.

Haggerty CM, Restrepo M, Tang E, de Zélicourt DA, Sundareswaran KS, Mirabella L, et al. Fontan hemodynamics from 100 patient-specific cardiac magnetic resonance studies: a computational fluid dynamics analysis. The Journal of thoracic and cardiovascular surgery. 2014;148(4):1481-9.

Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019;73(12):1494- 563.

Sachdeva R, Valente AM, Armstrong AK, Cook SC, Han BK, Lopez L, et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 appropriate use criteria for multimodality imaging during the follow-up care of patients with congenital heart disease: a report of the American College of Cardiology solution set oversight committee and appropriate use criteria task force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. Journal of the American College of Cardiology. 2020;75(6):657-703.

Esposito A, Francone M, Andreini D, Buffa V, Cademartiri F, Carbone I, et al. SIRM–SIC appropriateness criteria for the use of Cardiac Computed Tomography. Part 1: Congenital heart diseases, primary prevention, risk assessment before surgery, suspected CAD in symptomatic patients, plaque and epicardial adipose tissue characterization, and functional assessment of stenosis. La radiologia medica. 2021;126(9):1236-48.

Pontone G, Di Cesare E, Castelletti S, De Cobelli F, De Lazzari M, Esposito A, et al. Appropriate use criteria for cardiovascular magnetic resonance imaging (CMR): SIC—SIRM position paper part 1 (ischemic and congenital heart diseases, cardio-oncology, cardiac masses and heart transplant). La radiologia medica. 2021;126:365-79.

Argentiero A, Muscogiuri G, Rabbat MG, Martini C, Soldato N, Basile P, et al. The applications of artificial intelligence in cardiovascular magnetic resonance—a comprehensive review. Journal of Clinical Medicine. 2022;11(10):2866.

Nielles-Vallespin S, Khalique Z, Ferreira PF, de Silva R, Scott AD, Kilner P, et al. Assessment of myocardial microstructural dynamics by in vivo diffusion tensor cardiac magnetic resonance. Journal of the American College of Cardiology. 2017;69(6):661-76.

Ariga R, Tunnicliffe EM, Manohar SG, Mahmod M, Raman B, Piechnik SK, et al. Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias. Journal of the American College of Cardiology. 2019;73(20):2493-502.

Pennell DJ, Mohiaddin RH. Cardiovascular Magnetic Resonance: Past, Present, and Future. Circulation: Cardiovascular Imaging. 2024;17(8):e016523.

Friedrich MG, Niendorf T, Schulz-Menger J, Gross CM, Dietz R. Blood oxygen level– dependent magnetic resonance imaging in patients with stress-induced angina. Circulation. 2003;108(18):2219-23.